BR0215026A - Method for the treatment of bone disorders - Google Patents

Method for the treatment of bone disorders

Info

Publication number
BR0215026A
BR0215026A BR0215026-3A BR0215026A BR0215026A BR 0215026 A BR0215026 A BR 0215026A BR 0215026 A BR0215026 A BR 0215026A BR 0215026 A BR0215026 A BR 0215026A
Authority
BR
Brazil
Prior art keywords
treatment
bone disorders
methods
loading
dose
Prior art date
Application number
BR0215026-3A
Other languages
Portuguese (pt)
Inventor
Pamela Jean Schofield
Henry Van Den Berg
David Ernest Burgio
Arkadi Aaron Chines
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Priority claimed from PCT/US2002/040234 external-priority patent/WO2003055496A1/en
Publication of BR0215026A publication Critical patent/BR0215026A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"MéTODO PARA O TRATAMENTO DE DESORDENS óSSEAS". A presente invenção refere-se aos métodos para o tratamento de desordens ósseas em mamíferos que são apresentados. Os métodos compreendem um período de carga com um bifosfonato seguido de um período de manutenção. A dose de carga é duas a vinte vezes por dia maior que a dose de manutenção correspondente. São também apresentadas composições e kits para a implementação dos métodos aqui descritos."METHOD FOR TREATMENT OF BONE DISORDERS". The present invention relates to methods for the treatment of bone disorders in mammals which are disclosed. The methods comprise a bisphosphonate loading period followed by a maintenance period. The loading dose is two to twenty times a day higher than the corresponding maintenance dose. Compositions and kits for implementing the methods described herein are also presented.

BR0215026-3A 2001-12-21 2002-12-16 Method for the treatment of bone disorders BR0215026A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33487501P 2001-12-21 2001-12-21
PCT/US2002/040234 WO2003055496A1 (en) 2001-12-21 2002-12-16 Method for the treatment of bone disorders

Publications (1)

Publication Number Publication Date
BR0215026A true BR0215026A (en) 2004-11-09

Family

ID=33449516

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0215026-3A BR0215026A (en) 2001-12-21 2002-12-16 Method for the treatment of bone disorders

Country Status (1)

Country Link
BR (1) BR0215026A (en)

Similar Documents

Publication Publication Date Title
DE60229530D1 (en) SUBSTITUTED PIPERAZINE AS MODULATORS OF MELANOCORTINRECEPTOR
BR0317896A (en) Protein crystal complexes and ionic polymers
DE60224404D1 (en) SUBSTITUTED PIPERIDINES AS MELANOCORTIN RECEPTOR MODULATORS
BR0306724A (en) amino substituted carboxamides for treatment of alzheimer's disease
DE69815090D1 (en) USE OF CHOLINESTERASE INHIBITORS FOR TREATING CONCENTRATIONAL DISORDER
YU18400A (en) Prostaglandin agonists and their use to treat bone disorders
DE69936102D1 (en) USE OF TNF-ALPHA INHIBITORS FOR THE TREATMENT OF NERVE ROOT DAMAGE
NO20083956L (en) Prodrugs of GABA analogs, compositions and uses thereof
DE69729125D1 (en) TROPONIN SUB-UNITS AND FRAGMENTS FOR USE AS INHIBITORS OF ANGIOGENESIS
CY1107927T1 (en) PHOSPHONE COMPOUNDS
GB2364059A (en) Beta-Secretase enzyme compositions and methods
BR0318269A (en) compositions, targets, methods and devices for the therapy of ocular and periocular disorders
UY28280A1 (en) 2- HYDROXI - 3- DIAMINOALCANOS DE BENZAMIDA
PA8493701A1 (en) COMPOUNDS TO TREAT OBESITY
ATE390928T1 (en) COMPOSITIONS FOR TREATING SKIN DISEASES
BR0307522A (en) Use of a lipoxygenase-15 inhibitor for the manufacture of a medicament, methods for treatment and prevention, and kit for diagnosing predisposition to bone loss.
BRPI0408477A (en) phosphate / sulfate ester compounds and pharmaceutical compositions for inhibiting the use of protein (pin 1) and their use
ATE232874T1 (en) PROSTAGLANDIN CONJUGATES FOR THE TREATMENT OF BONE DISEASES
AP9801269A0 (en) Prostaglandin agonists.
ATE554169T1 (en) SMAD7 INHIBITORS FOR THE TREATMENT OF CNS DISEASES
BR0313624A (en) 5ht2a receptor agonism for treatment of thermoregulatory dysfunction
BR0309406A (en) Pharmaceutical composition, preparation process, kit and methods for treating obesity, use of lipase composition and inhibitor, lipase inhibitor and glucomannan or konjac and their use and method of treatment
DE60015508T2 (en) C-16 UNAUDITED FP-SELECTIVE PROSTAGLANDIN ANALOGUE
BR9808784A (en) Method for the treatment of mental illness in mammals and a composition for the same
BR0215026A (en) Method for the treatment of bone disorders

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B25A Requested transfer of rights approved

Owner name: WARNER CHILCOTT COMPANY, LLC (PR)

B12B Appeal against refusal [chapter 12.2 patent gazette]
B25E Requested change of name of applicant rejected

Owner name: WARNER CHILCOTT COMPANY, LLC (PR)